Magni Arianna, Mattiello Sara, Beverina Luca, Mattioli Giuseppe, Moschetta Matteo, Zucchi Anita, Paternò Giuseppe Maria, Lanzani Guglielmo
Department of Physics, Politecnico di Milano 20133 Milan Italy
Center for Nano Science and Technology @PoliMi, Istituto Italiano di Tecnologia 20133 Milan Italy
Chem Sci. 2023 Jul 5;14(30):8196-8205. doi: 10.1039/d3sc01168b. eCollection 2023 Aug 2.
Photodynamic inhibition (PDI) of bacteria represents a powerful strategy for dealing with multidrug-resistant pathogens and infections, as it exhibits minimal development of antibiotic resistance. The PDI action stems from the generation of a triplet state in the photosensitizer (PS), which subsequently transfers energy or electrons to molecular oxygen, resulting in the formation of reactive oxygen species (ROS). These ROS are then able to damage cells, eventually causing bacterial eradication. Enhancing the efficacy of PDI includes the introduction of heavy atoms to augment triplet generation in the PS, as well as membrane intercalation to circumvent the problem of the short lifetime of ROS. However, the former approach can pose safety and environmental concerns, while achieving stable membrane partitioning remains challenging due to the complex outer envelope of bacteria. Here, we introduce a novel PS, consisting of a metal-free donor-acceptor thiophene-based conjugate molecule (BV-1). It presents several advantageous features for achieving effective PDI, namely: (i) it exhibits strong light absorption due to the conjugated donor-acceptor moieties; (ii) it exhibits spontaneous and stable membrane partitioning thanks to its amphiphilicity, accompanied by a strong fluorescence turn-on; (iii) it undergoes metal-free intersystem crossing, which occurs preferentially when the molecule resides in the membrane. All these properties, which we rationalized optical spectroscopies and calculations, enable the effective eradication of , with an inhibition concentration that is below that of current state-of-the-art treatments. Our approach holds significant potential for the development of new PS for controlling bacterial infections, particularly those caused by Gram-negative bacteria.
细菌的光动力抑制(PDI)是应对多重耐药病原体和感染的有力策略,因为它产生抗生素耐药性的可能性极小。PDI作用源于光敏剂(PS)中三重态的产生,随后三重态将能量或电子转移给分子氧,导致活性氧(ROS)的形成。这些ROS随后能够损伤细胞,最终导致细菌被根除。提高PDI的疗效包括引入重原子以增加PS中三重态的产生,以及进行膜插入以解决ROS寿命短的问题。然而,前一种方法可能会带来安全和环境问题,而由于细菌复杂的外膜,实现稳定的膜分配仍然具有挑战性。在此,我们引入了一种新型的PS,它由一种无金属的供体-受体噻吩基共轭分子(BV-1)组成。它具有实现有效PDI的几个有利特征,即:(i)由于共轭的供体-受体部分,它表现出强烈的光吸收;(ii)由于其两亲性,它表现出自发且稳定的膜分配,并伴随着强烈的荧光开启;(iii)它经历无金属的系间窜越,当分子位于膜中时优先发生。我们通过光谱学和计算对所有这些性质进行了合理化解释,这些性质能够有效根除细菌,其抑制浓度低于当前最先进治疗方法的抑制浓度。我们的方法在开发用于控制细菌感染,特别是由革兰氏阴性菌引起的感染的新型PS方面具有巨大潜力。